Wyeth Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WYETH PHARMS
WYETH PHARMS has thirty-one approved drugs.
There are two US patents protecting WYETH PHARMS drugs.
There are fifty-six patent family members on WYETH PHARMS drugs in thirty countries and thirty-six supplementary protection certificates in thirteen countries.
Summary for Wyeth Pharms
| International Patents: | 56 |
| US Patents: | 2 |
| Tradenames: | 29 |
| Ingredients: | 18 |
| NDAs: | 31 |
Drugs and US Patents for Wyeth Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | EFFEXOR | venlafaxine hydrochloride | TABLET;ORAL | 020151-001 | Dec 28, 1993 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wyeth Pharms | PROTONIX | pantoprazole sodium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 022020-001 | Nov 14, 2007 | AB | RX | Yes | Yes | 7,544,370*PED | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Wyeth Pharms Inc | EFFEXOR | venlafaxine hydrochloride | TABLET;ORAL | 020151-004 | Dec 28, 1993 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wyeth Pharms Inc | NORPLANT SYSTEM IN PLASTIC CONTAINER | levonorgestrel | IMPLANT;IMPLANTATION | 020088-001 | Dec 10, 1990 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wyeth Pharms Inc | LODINE | etodolac | CAPSULE;ORAL | 018922-003 | Jan 31, 1991 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wyeth Pharms | DUAVEE | bazedoxifene acetate; estrogens, conjugated | TABLET;ORAL | 022247-001 | Oct 3, 2013 | RX | Yes | Yes | 7,683,051 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Wyeth Pharms | INDERAL | propranolol hydrochloride | TABLET;ORAL | 016418-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Wyeth Pharms
Paragraph IV (Patent) Challenges for WYETH PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | For Injection | 12 g/1.5 g per vial (pharmacy bulk) | ➤ Subscribe | 2011-12-06 |
| ➤ Subscribe | Tablets | 0.09 mg/0.02 mg | ➤ Subscribe | 2007-10-05 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg and 40 mg | ➤ Subscribe | 2004-02-02 |
| ➤ Subscribe | Tablets | 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg | ➤ Subscribe | 2005-11-03 |
International Patents for Wyeth Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Peru | 20060676 | ⤷ Start Trial |
| Australia | 2004278037 | ⤷ Start Trial |
| Taiwan | 200606149 | ⤷ Start Trial |
| Argentina | 048527 | ⤷ Start Trial |
| Ecuador | SP066538 | ⤷ Start Trial |
| Spain | 2529570 | ⤷ Start Trial |
| China | 1886119 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Wyeth Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0166287 | SPC/GB96/056 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: PANTOPRAZOLE AND ITS SALTS, HYDRATES AND HYDRATES OF ITS SALTS; REGISTERED: SE SE12131 19940506; UK 04889/0010 19960604 |
| 0802183 | 09C0048 | France | ⤷ Start Trial | PRODUCT NAME: BAZEDOXIFENE ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/09/511/001 DU 20090417; REGISTRATION NO/DATE AT EEC: EU/1/09/511/001-004 DU 20090417 |
| 0454511 | SPC/GB99/008 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE)(GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/98/086/001 19981015; UK EU/1/98/086/002 19981015; UK EU/1/98/086/003 19981015; UK EU/1/98/086/004 19981015; UK EU/1/98/086/005 19981015; UK EU/1/98/086/006 19981015 |
| 0503785 | CA 2011 00026 | Denmark | ⤷ Start Trial | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
| 1539166 | 92323 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: LA COMBINAISON DE (A) DEXTROMETHORPHAN OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, PRECURSEURS OU DERIVES , PAR EX. HYDROBROMURE DE DEXTROMETHORPHAN ET EN PARTICULIER HYDROBROMURE DE DEXTROMETHORPHAN MONOHYDRATE; ET(B) QUINIDINE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES , PRECURSEURS OU DERIVES, PAR EX. SULFATE DE QUINIDINE ET EN PARTICULIER SULFATE DE QUINIDINE DEHYDRATE; FIRST REGISTRATION: 20130624 |
| 0802183 | 2009/028 | Ireland | ⤷ Start Trial | PRODUCT NAME: BAZEDOXIFENE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTRATION NO/DATE: EU/1/09/511/001-004 20090417 |
| 0454511 | 99C0009 | Belgium | ⤷ Start Trial | PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
